A class action lawsuit has been filed against Picard Medical Inc. on behalf of investors who purchased or acquired shares between September 2, 2025, and October 31, 2025. The complaint alleges that the company and its insiders engaged in a fraudulent stock promotion scheme that used social media misinformation and impersonated financial professionals. It is further claimed that insiders or affiliates coordinated the dumping of shares through offshore accounts during a campaign to inflate the stock price, and that Picard's public statements failed to disclose these activities and related risks. Investors have until April 3, 2026, to seek appointment as lead plaintiff in the case. The law firm handling the litigation encourages affected investors or those with relevant information to come forward.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602141126PR_NEWS_USPR_____NY87973) on February 14, 2026, and is solely responsible for the information contained therein.